Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction

Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction

Many patients, following therapy for acute myocardial infarction, develop adverse cardiac remodelling. Here the authors present injectable recombinant human collagen 10 of 10 type I and III matrices that are able to limit adverse remodelling and improve function of the myocardium.

Saved in:
Bibliographic Details
Main Authors: Sarah McLaughlin, Brian McNeill, James Podrebarac, Katsuhiro Hosoyama, Veronika Sedlakova, Gregory Cron, David Smyth, Richard Seymour, Keshav Goel, Wenbin Liang, Katey J. Rayner, Marc Ruel, Erik J. Suuronen, Emilio I. Alarcon
Format: article
Language:EN
Published: Nature Portfolio 2019
Subjects:
Science
Q
Online Access:https://doaj.org/article/87f2d71678a14732bc74e04f815a25a6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/87f2d71678a14732bc74e04f815a25a6

Similar Items